- Karl Storz has launched Tele Pack+, a compact endoscopy system in March’2020. The system is a transportable video system that assists in merging all of the key components, such as light source, display and camera control unit together required for diagnosis and treatment.
- Gynesonics, developed Sonata System in July’2020. The system is transcervical fibroid ablation system that makes use of radiofrequency energy for treating symptomatic uterine fibroids. The system detects and then target a single fibroid with a combination of radiofrequency and ultrasound.
Frequently Asked Questions
The market is segmented based on Segmentation, By Technology (Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Techniques), Mode of Treatment (Invasive Treatment, Minimally Invasive Treatment, Non-Invasive Treatment) – Industry Trends and Forecast to 2032
.
The Global Uterine Fibroid Embolization Devices Market size was valued at USD 5.70 USD Billion in 2024.
The Global Uterine Fibroid Embolization Devices Market is projected to grow at a CAGR of 4.4% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
